←
BioTuesdays7,801 posts
BioTuesdays avatar

BioTuesdays

@BioTuesdays

Giving great healthcare companies and their stories as much exposure as we can. Subscribe to our newsletter. biotuesdays.com/subscribe/

◷ Joined September 2009▧ 243 Photos and videos
BioTuesdays avatar
BioTuesdays@BioTuesdays·14 Feb 2025

Medicus Pharma announced that its SKNJCT-003 Phase 2 study, evaluating the efficacy of two dose levels of D-MNA for the treatment of nodular basal cell carcinoma (BCC), has now randomized more than 50% of the 60 patients targeted for enrollment $MDCX biotuesdays.com/2025/02/14/m…

BioTuesdays avatar
BioTuesdays@BioTuesdays·10 Feb 2025

Biodexa Pharmaceuticals has announced that eRapa, a form of rapamycin being developed for the treatment of familial adenomatous polyposis (FAP), has been granted Fast Track Designation by the FDA $BDRX biotuesdays.com/2025/02/10/f…

BioTuesdays avatar
BioTuesdays@BioTuesdays·10 Feb 2025

Esko Bionics names National Seating & Mobility as exclusive distributor of Ekso Indego Personal device within the complex rehabilitation technology industry $EKSO biotuesdays.com/2025/02/10/e…

BioTuesdays avatar
BioTuesdays@BioTuesdays·4 Feb 2025

In our latest #BioTuesdays feature, CEO Melissa Sherman, Ph.D., shares how @MobilionSystems, is redefining analytical characterization with next-gen separation science. biotuesdays.com/2025/02/04/m…

BioTuesdays avatar
BioTuesdays@BioTuesdays·30 Jan 2025

Tectonic Therapeutic has announced positive interim data from its Phase 1b acute hemodynamic clinical trial of TX45 in Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) $TECX biotuesdays.com/2025/01/30/t…

BioTuesdays avatar
BioTuesdays@BioTuesdays·30 Jan 2025

Polyrizon has announced the filing of a patent application for its advanced intranasal drug delivery system Trap & Target (T&T) technology, with the Israel Patent Office (ILPO) $PLRZ biotuesdays.com/2025/01/30/p…

BioTuesdays avatar
BioTuesdays@BioTuesdays·28 Jan 2025

Conduit Pharmaceuticals has announced that the first phase in its collaboration with Sarborg, aimed at integrating advanced AI and cybernetics technology into its operations has been completed $CDT biotuesdays.com/2025/01/28/c…

BioTuesdays avatar
BioTuesdays@BioTuesdays·27 Jan 2025

Stereotaxis has announced that it has received European CE Mark approval for its MAGIC ablation catheter, designed to perform cardiac ablation procedures aimed at treating heart arrhythmia $STXS biotuesdays.com/2025/01/27/s…